This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.
Our group is focused on exploring the role of the endocannabinoid system in the development of diabetes and its metabolic complications such as chronic kidney disease, liver injury, osteoporosis and mitochondrial dysfunction.